About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker YARW

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Nov 13, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Daniel Mack39,1980.5%SCHEDULE 13G/A ↗
Nov 13, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Wilmot B. Harkey39,1980.5%SCHEDULE 13G/A ↗
Nov 13, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Nantahala Capital Management, LLC39,1980.5%SCHEDULE 13G/A ↗
Nov 13, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Simon Basseyn607,3826.4%SCHEDULE 13G ↗
Nov 13, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Alex R. Rosen607,3826.4%SCHEDULE 13G ↗
Nov 13, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Spruce Street Capital LP607,3826.4%SCHEDULE 13G ↗
Oct 7, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Bellevue Asset Management AG1.00M10.6%SCHEDULE 13G ↗
Oct 7, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Bellevue Group AG1.00M10.6%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Raymond Debbane675,0007.2%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Ulys, L.L.C.83,5280.9%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Avicenna Life Sci Master GP LLC83,5280.9%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Avicenna Life Sci Master Fund LP83,5280.9%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Siren, L.L.C.591,4726.3%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Invus Global Management, LLC591,4726.3%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Invus Public Equities Advisors, LLC591,4726.3%SCHEDULE 13G ↗
Sep 17, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Invus Public Equities, L.P.591,4726.3%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Daniel Schneeberger59,0008.8%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
ADAR1 Capital Management, LLC59,0008.8%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
venBio Global Strategic GP V, LLC279,34010.0%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
venBio Global Strategic Fund V, L.P.279,34010.0%SCHEDULE 13G ↗
Aug 13, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Zhang Xiaofan162,4520.6%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
JANUS HENDERSON GROUP Ltd.266,71210.0%SCHEDULE 13G ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Graham Walmsley109,6304.1%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
William Arsani286,30810.7%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Logos Opportunities V GP LLC109,6304.1%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Logos Opportunities Fund V LP109,6304.1%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Logos GP LLC176,6786.6%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Logos Global Master Fund LP176,6786.6%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Logos Global Management GP LLC286,30810.7%SCHEDULE 13G/A ↗
Aug 7, 2026SCHEDULE 13G/A (amended)YARW
Yarrow Bioscience, Inc.
Logos Global Management LP286,30810.7%SCHEDULE 13G/A ↗
Aug 5, 2026SCHEDULE 13DYARW
Yarrow Bioscience, Inc.
OrbiMed Genesis GP LLC33,2871.3%SCHEDULE 13D ↗
Aug 5, 2026SCHEDULE 13DYARW
Yarrow Bioscience, Inc.
OrbiMed Capital GP X, LP233,0198.7%SCHEDULE 13D ↗
Aug 5, 2026SCHEDULE 13DYARW
Yarrow Bioscience, Inc.
OrbiMed Capital GP X LLC233,0198.7%SCHEDULE 13D ↗
Aug 5, 2026SCHEDULE 13DYARW
Yarrow Bioscience, Inc.
Orbimed Advisors LLC266,30610.0%SCHEDULE 13D ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Graham Walmsley256,7049.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
William Arsani276,7049.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Logos Opportunities V GP LLC256,7049.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Logos Opportunities Fund V LP256,7049.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Logos GP LLC120,0269.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Logos Global Master Fund LP120,0269.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Logos Global Management GP LLC276,7049.9%SCHEDULE 13G ↗
Aug 4, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Logos Global Management LP276,7049.9%SCHEDULE 13G ↗
Aug 3, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Perceptive Life Sciences Master Fund, Ltd.266,75610.0%SCHEDULE 13G ↗
Aug 3, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Joseph Edelman266,75610.0%SCHEDULE 13G ↗
Aug 3, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Perceptive Advisors LLC266,75610.0%SCHEDULE 13G ↗
Jul 30, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
Roderick Wong266,30710.0%SCHEDULE 13G ↗
Jul 30, 2026SCHEDULE 13GYARW
Yarrow Bioscience, Inc.
RTW Fund Group GP, LLC266,30710.0%SCHEDULE 13G ↗
Jul 29, 2026SCHEDULE 13D/A (amended)YARW
Yarrow Bioscience, Inc.
Len Blavatnik178,1806.0%SCHEDULE 13D/A ↗
Jul 29, 2026SCHEDULE 13D/A (amended)YARW
Yarrow Bioscience, Inc.
Access Industries Management, LLC178,1806.0%SCHEDULE 13D/A ↗
Jul 29, 2026SCHEDULE 13D/A (amended)YARW
Yarrow Bioscience, Inc.
Access Industries Holdings LLC178,1806.0%SCHEDULE 13D/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:50 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances